论文部分内容阅读
目的观察兰索拉唑联合氟哌噻吨美利曲辛治疗功能性消化不良的效果及其用药安全性。方法选取90例功能性消化不良患者为观察对象,按随机数字表法分为A、B组两组,每组45例。A组患者给予兰索拉唑治疗,B组患者给予兰索拉唑联合氟哌噻吨美利曲辛治疗。连续治疗8周,比较两组疗效及药物副作用。结果 A组显效29例,有效9例,无效7例。B组显效40例,有效4例,无效1例。B组疗效优于A组(P<0.01)。B组患者药物不良反应发生率与A组比较差异无统计学意义(P>0.05)。结论兰索拉唑联合氟哌噻吨美利曲辛能够有效改善功能性消化不良患者临床症状,安全高效、副作用少,值得临床推广应用。
Objective To observe the efficacy and safety of lansoprazole combined with flupentixol and melitracen in the treatment of functional dyspepsia. Methods Totally 90 patients with functional dyspepsia were selected as subjects and divided into groups A and B according to the random number table method, with 45 cases in each group. Patients in group A received lansoprazole, and patients in group B received lansoprazole plus flupentixol and melitracen. Continuous treatment for 8 weeks, the two groups were compared efficacy and drug side effects. Results In group A, 29 cases were markedly effective, 9 cases were effective, and 7 cases were ineffective. Group B markedly effective in 40 cases, effective in 4 cases, 1 case of ineffective. The efficacy of group B was better than that of group A (P <0.01). The incidence of adverse drug reactions in group B was not significantly different from that in group A (P> 0.05). Conclusions Lansoprazole combined with flupentixol and melitracen can effectively improve clinical symptoms of patients with functional dyspepsia, which is safe and effective with few side effects and is worthy of clinical application.